Brian Greven
Brian Greven has over 25 years of experience working in the biomanufacturing industry developing and manufacturing biopharmaceuticals with both innovator companies and CDMOs. He has worked for some of the leading biotechnology companies including Boehringer Ingelheim and Samsung Biologics. He has led technology transfers to CDMOs and has also been the main point of contact at the CDMO for technology transfer. His oversight of projects has starting from Cell Line Development to GMP manufacturing, allowing him to oversee the generation of material for both development and clinic trials. Throughout the years in the industry he has been the subject matter expert during regulatory agencies audits for reviews of BLA filings and also general GMP facility audits.